NAVELBINE (vinorelbine tartrate)
Injection is indicated as a single agent or in combination with cisplatin
for the first-line treatment of ambulatory patients with advanced,
unresectable NSCLC.
- In stage III patients, NAVELBINE is indicated for use in
combination with cisplatin.
- In stage IV patients, NAVELBINE is indicated for use as a single
agent or in combination with cisplatin.
Administration of NAVELBINE is contraindicated in patients with
pretreatment granulocyte counts of less than 1,000 cells/cubic mm.
